SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc of Class Action Lawsuit and Upcoming Deadline – SAVA forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Methylphenidate is associated with a significantly greater reduction in apathy in patients with Alzheimer s disease compared with placebo and has a good safety profile, a new phase 3 trial suggests.
/PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA).
Stimulant Reduces Apathy in Alzheimer s Disease medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.
Cassava Sciences Announces Positive Cognition Data With Simufilam in Alzheimer s Disease biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.